Copper(less) Committee

MIA's scientific advisory body, established March 2021. A multidisciplinary team of scientists, physicians, pharmacists and families working pro bono.

Mission

The Copper(less) Committee was established in March 2021 as the scientific advisory body of MIA. Its founding purpose was to develop the first dosing plan for human use for the exceptional treatment with elesclomol-copper (Es-Cu) for Menkes patients.

The committee comprises scientists, researchers, medical doctors, pharmacometricians, pharmacists, chemists, biologists and family members. All serve on a pro bono basis.

Elesclomol-Copper (Es-Cu) Exceptional Treatments

The committee develops and oversees the dosing plan for elesclomol-copper exceptional treatment for authorised patients — the first such protocol for human use.

Early Diagnosis Protocols

Developing and disseminating clinical protocols to improve early diagnosis of Menkes disease, including the bilingual brochure distributed to paediatricians worldwide.

Ongoing Research Projects

Members contribute to active research initiatives across genetics, pharmacology, biochemistry and clinical care.

Weekly Scientific Meetings

The committee meets every Friday at 16:00 CET to review cases, discuss treatment options and coordinate new initiatives.

Early Diagnosis Brochure

Produced by the Copper(less) Committee — available in English

Download PDF

Rules of Procedure

Internal operating rules of the Copper(less) Committee (signed)

Download PDF

NPP-Menkes — Free Treatment Program

Named-Patients Program with Elesclomol-Copper. 9 children treated in Spain and Switzerland. Treatment provided completely free of charge.

Learn more

Committee Members

Dr. Nina Horn

Kennedy Center, Copenhagen

Professor Francesc Palau

Chair

Hospital Sant Joan de Déu, Barcelona

Professor Michael Petris

University of Missouri, School of Medicine

Professor Elisabeth de Lange

Leiden University

Dr. James Sacchettini

Texas A&M University, USA

Dr. Raphaël Rodriguez (FRSC)

Institut Curie, Paris, France

Merce Capdevila

Universitat Autònoma de Barcelona

Dr. Vishal Gohil

Texas A&M University, USA

MD Natalia Serrano

Engrail Therapeutics

MD Elena Godoy

Hospital Materno-Infantil de Málaga, Spain

Dr. Prachi Trivedi

Texas A&M University, USA

Dr. Julian Mercer

Deakin University, Melbourne

Bibudhendra Sarkar

SickKids Hospital, Toronto

Professor Joseph Standing

UCL Institute of Child Health

Svetlana Lutsenko

Johns Hopkins University, USA

Victor Mangas

University of Valencia, Spain

Christos Papageorgiou

University of Missouri, USA

Denis Broun

Menkes International

Aurora Mateos

Secretary

Menkes International Association